Literature DB >> 18515493

Role of the lysozyme inhibitor Ivy in growth or survival of Escherichia coli and Pseudomonas aeruginosa bacteria in hen egg white and in human saliva and breast milk.

Daphne Deckers1, Dietrich Vanlint, Lien Callewaert, Abram Aertsen, Chris W Michiels.   

Abstract

Ivy is a lysozyme inhibitor that protects Escherichia coli against lysozyme-mediated cell wall hydrolysis when the outer membrane is permeabilized by mutation or by chemical or physical stress. In the current work, we have investigated whether Ivy is necessary for the survival or growth of E. coli MG1655 and Pseudomonas aeruginosa PAO1 in hen egg white and in human saliva and breast milk, which are naturally rich in lysozyme and in membrane-permeabilizing components. Wild-type E. coli was able to grow in saliva and breast milk but showed partial inactivation in egg white. The knockout of Ivy did not affect growth in breast milk but slightly increased sensitivity to egg white and caused hypersensitivity to saliva, resulting in the complete inactivation of 10(4) CFU ml(-1) of bacteria within less than 5 hours. The depletion of lysozyme from saliva completely restored the ability of the ivy mutant to grow like the parental strain. P. aeruginosa, in contrast, showed growth in all three substrates, which was not affected by the knockout of Ivy production. These results indicate that lysozyme inhibitors like Ivy promote bacterial survival or growth in particular lysozyme-rich secretions and suggest that they may promote the bacterial colonization of specific niches in the animal host.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18515493      PMCID: PMC2493159          DOI: 10.1128/AEM.00589-08

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  36 in total

1.  Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme.

Authors:  V Monchois; C Abergel; J Sturgis; S Jeudy; J M Claverie
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

2.  Processing of lysozyme at distinct loops by pepsin: a novel action for generating multiple antimicrobial peptide motifs in the newborn stomach.

Authors:  Hisham R Ibrahim; Daisuke Inazaki; Adham Abdou; Takayoshi Aoki; Mujo Kim
Journal:  Biochim Biophys Acta       Date:  2005-08-03

3.  Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria.

Authors:  Chantal Abergel; Vincent Monchois; Deborah Byrne; Sabine Chenivesse; Frédérique Lembo; Jean-Claude Lazzaroni; Jean-Michel Claverie
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

4.  Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues.

Authors:  Jan Wehkamp; Hiutung Chu; Bo Shen; Ryan W Feathers; Robert J Kays; Sarah K Lee; Charles L Bevins
Journal:  FEBS Lett       Date:  2006-09-12       Impact factor: 4.124

5.  The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae.

Authors:  W Vollmer; A Tomasz
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

6.  Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism.

Authors:  H R Ibrahim; Y Sugimoto; T Aoki
Journal:  Biochim Biophys Acta       Date:  2000-10-18

7.  Overview of nosocomial infections caused by gram-negative bacilli.

Authors:  Robert Gaynes; Jonathan R Edwards
Journal:  Clin Infect Dis       Date:  2005-08-16       Impact factor: 9.079

8.  Consumption of milk from transgenic goats expressing human lysozyme in the mammary gland results in the modulation of intestinal microflora.

Authors:  Elizabeth A Maga; Richard L Walker; Gary B Anderson; James D Murray
Journal:  Transgenic Res       Date:  2006-08       Impact factor: 3.145

Review 9.  Antimicrobial proteins and polypeptides in pulmonary innate defence.

Authors:  Mark P Rogan; Patrick Geraghty; Catherine M Greene; Shane J O'Neill; Clifford C Taggart; Noel G McElvaney
Journal:  Respir Res       Date:  2006-02-17

10.  A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria.

Authors:  Lien Callewaert; Abram Aertsen; Daphne Deckers; Kristof G A Vanoirbeek; Lise Vanderkelen; Joris M Van Herreweghe; Barbara Masschalck; Dorothy Nakimbugwe; Johan Robben; Chris W Michiels
Journal:  PLoS Pathog       Date:  2008-03-07       Impact factor: 6.823

View more
  20 in total

Review 1.  Lysozymes in the animal kingdom.

Authors:  Lien Callewaert; Chris W Michiels
Journal:  J Biosci       Date:  2010-03       Impact factor: 1.826

2.  The vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylase.

Authors:  Chelsea A Clarke; Edie M Scheurwater; Anthony J Clarke
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

3.  Phenotypic differences between coryneform bacteria isolated from seminal fluid of healthy men and men with chronic prostatitis syndrome.

Authors:  Iuri B Ivanov; Viktor A Gritsenko; Michael D Kuzmin
Journal:  Asian J Androl       Date:  2009-05-18       Impact factor: 3.285

4.  Detection of a lysozyme inhibitor in Proteus mirabilis by a new reverse zymogram method.

Authors:  Lien Callewaert; Lise Vanderkelen; Daphne Deckers; Abram Aertsen; Johan Robben; Chris W Michiels
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

Review 5.  Invertebrate lysozymes: diversity and distribution, molecular mechanism and in vivo function.

Authors:  Joris M Van Herreweghe; Chris W Michiels
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

6.  Edwardsiella tarda MliC, a lysozyme inhibitor that participates in pathogenesis in a manner that parallels Ivy.

Authors:  Mo-Fei Li; Chong Wang; Li Sun
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

7.  Identification of a bacterial inhibitor against g-type lysozyme.

Authors:  L Vanderkelen; J M Van Herreweghe; K G A Vanoirbeek; G Baggerman; B Myrnes; P J Declerck; I W Nilsen; C W Michiels; L Callewaert
Journal:  Cell Mol Life Sci       Date:  2010-08-25       Impact factor: 9.261

8.  Goose-type lysozyme inhibitor (PliG) enhances survival of Escherichia coli in goose egg albumen.

Authors:  Lise Vanderkelen; Joris M Van Herreweghe; Lien Callewaert; Chris W Michiels
Journal:  Appl Environ Microbiol       Date:  2011-05-20       Impact factor: 4.792

9.  Edwardsiella tarda Ivy, a lysozyme inhibitor that blocks the lytic effect of lysozyme and facilitates host infection in a manner that is dependent on the conserved cysteine residue.

Authors:  Chong Wang; Yong-hua Hu; Bo-guang Sun; Jun Li; Li Sun
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

10.  Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme.

Authors:  J M Van Herreweghe; L Vanderkelen; L Callewaert; A Aertsen; G Compernolle; P J Declerck; C W Michiels
Journal:  Cell Mol Life Sci       Date:  2010-01-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.